Filing Details
- Accession Number:
- 0001225208-14-006875
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-28 16:16:19
- Reporting Period:
- 2014-02-27
- Filing Date:
- 2014-02-28
- Accepted Time:
- 2014-02-28 16:16:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885725 | Boston Scientific Corp | BSX | Surgical & Medical Instruments & Apparatus (3841) | 042695240 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1529751 | A David Pierce | One Boston Scientific Place Natick MA 01760-1537 | Svp And President, Endoscopy | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-27 | 3,981 | $0.00 | 49,199 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-27 | 3,185 | $0.00 | 52,384 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-27 | 2,057 | $13.29 | 50,327 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-27 | 2,337 | $13.30 | 47,990 | No | 4 | F | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | F | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Deferred Stock Units | Disposition | 2014-02-27 | 3,981 | $0.00 | 3,981 | $0.00 |
Common Stock | Deferred Stock Units | Disposition | 2014-02-27 | 3,185 | $0.00 | 3,185 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,981 | 2015-02-27 | No | 4 | M | Direct | |
9,555 | 2017-02-27 | No | 4 | M | Direct |
Footnotes
- Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan.
- Shares of common stock will be issued to the reporting person in three equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant
- Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.